Sacubitril-valsartan reduced NT-proBNP more than enalapril in acute heart failure | ACP Hospitalist Weekly | ACP Hospitalist
The industry-funded trial found similar rates of renal failure, hyperkalemia, symptomatic hypotension, and angioedema whether patients started sacubitril-valsartan or enalapril during their heart failure hospitalization.
Financial penalties have failed to dent readmissions, so new strategies are needed.
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
Physician-specific discharge practice patterns related to LOS in heart failure | ACP Hospitalist Weekly | ACP Hospitalist
A survey administered to cardiologists and hospitalists at one hospital asked about the influence of 10 discharge readiness factors, including physical examination findings, diuretics, and kidney function, on discharge decisions.
For coding purposes, it is no longer enough to say that patients have “CHF” or “congestive heart failure.”.
Hospitalizations rose for acute decompensated heart failure in past decade | ACP Hospitalist Weekly | ACP Hospitalist
The analysis of heart failure-related hospitalizations in U.S. patients age 55 years and older between 2005 and 2014 found that only black patients showed decreased one-year mortality over time.
Cases involving heart failure are presented.
NT-proBNP cutpoints validated for diagnosing and ruling out heart failure in the ED | ACP Hospitalist Weekly | ACP Hospitalist
Age-stratified cutpoints for N-terminal pro–B-type natriuretic peptide (NT-proBNP) helped diagnose acute heart failure, and 300 pg/mL had good sensitivity and negative predictive value as a rule-out cutpoint, the study found.
Sacubitril/valsartan attracted attention even before approval.
New and revised recommendations on the treatment of heart failure were released last week jointly by the American College of Cardiology Foundation and American Heart Association.